ArticleJournal of experimental & clinical cancer research : CR2025

Liensinine reshapes the immune microenvironment and enhances immunotherapy by reprogramming metabolism through the AMPK-HIF-1α axis in hepatocellular carcinoma.

Jiahao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.